Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
06-10 April, 2025
Not Confirmed
Not Confirmed
07-11 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
06-10 April, 2025
Industry Trade Show
Not Confirmed
07-11 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
11 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-welcomes-immunology-and-infectious-disease-expert-dr-ashley-st-john-to-its-scientific-advisory-board-302398346.html
27 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-answers-surgeon-generals-alarm-with-a-new-therapeutic-aimed-at-tackling-alcohol-related-risks-302360784.html
22 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-secures-financial-and-strategic-investment-from-5-horizons-capital-to-advance-sjp-001-clinical-trial-with-novotech-302357405.html
15 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-announces-preliminary-results-from-phase-2-clinical-trials-of-sjp-002c-for-upper-respiratory-infectionscovid-19-302351799.html
14 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-announces-ethics-approval-in-australia-for-sjp-001-clinical-trial-targeting-inflammation-and-metabolic-health-302350496.html
13 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sen-jam-pharmaceutical-revolutionizing-inflammatory-care-with-proprietary-pair-technology-for-metabolic-balance-and-inflammation-resolution-302349294.html
ABOUT THIS PAGE